Martingale Asset Management »

Kalvista Pharmaceuticals shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $500k 31k 16.15

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Cisco Systems (CSCO)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Visa (V)
Exxon Mobil Corporation (XOM)
Wal-Mart Stores (WMT)
NVIDIA Corporation (NVDA)
MasterCard Incorporated (MA)

View all positions for Martingale Asset Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
Woodline Partners
State Street Corporation
Vestal Point Capital
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals